Retractable Technologies, Inc. (NYSE:RVP) CEO Acquires $10,080.45 in Stock

Retractable Technologies, Inc. (NYSE:RVP) CEO Thomas J. Shaw acquired 12,445 shares of the stock in a transaction that occurred on Monday, January 27th. The stock was acquired at an average cost of $0.81 per share, for a total transaction of $10,080.45. Following the completion of the purchase, the chief executive officer now owns 15,019,308 shares in the company, valued at $12,165,639.48. The trade was a 0.08 % increase in their position. The purchase was disclosed in a legal filing with the SEC, which is accessible through the SEC website.

Retractable Technologies Stock Performance

Shares of NYSE:RVP opened at $0.80 on Wednesday. The company has a current ratio of 8.57, a quick ratio of 5.92 and a debt-to-equity ratio of 0.01. The business’s fifty day moving average price is $0.68 and its two-hundred day moving average price is $0.82. Retractable Technologies, Inc. has a one year low of $0.56 and a one year high of $1.34.

Institutional Trading of Retractable Technologies

An institutional investor recently bought a new position in Retractable Technologies stock. PFG Investments LLC bought a new stake in Retractable Technologies, Inc. (NYSE:RVP) during the third quarter, according to its most recent 13F filing with the SEC. The institutional investor bought 34,600 shares of the company’s stock, valued at approximately $27,000. PFG Investments LLC owned approximately 0.12% of Retractable Technologies at the end of the most recent quarter. 7.58% of the stock is currently owned by institutional investors.

Wall Street Analyst Weigh In

Separately, StockNews.com initiated coverage on shares of Retractable Technologies in a report on Wednesday, January 22nd. They issued a “hold” rating on the stock.

Retractable Technologies Company Profile

Retractable Technologies, Inc designs, develops, manufactures, and markets safety syringes and other safety medical products for the healthcare profession in the United States, rest of North and South America, and internationally. The company offers VanishPoint insulin syringes; tuberculin, insulin, and allergy antigen syringes; small diameter tube adapters; blood collection tube holders; allergy trays; IV safety catheters; Patient Safe syringes and Luer Caps; VanishPoint blood collection sets; EasyPoint needles; and VanishPoint autodisable syringes.